Clinical pharmacologic studies of L-asparaginase.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001215:Asparaginase / Q000097:blood / Q000627:therapeutic use*; D001216:Asparagine / Q000134:cerebrospinal fluid / Q000652:urine; D001806:Blood Urea Nitrogen; D001859:Bone Neoplasms / Q000188:drug therapy; D001943:Breast Neoplasms / Q000188:drug therapy; D002648:Child; D003080:Cold Temperature; D005260:Female; D005615:Freezing; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007680:Kidney Neoplasms / Q000188:drug therapy; D007770:L-Lactate Dehydrogenase / Q000097:blood; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000188:drug therapy; D013997:Time Factors
D001216:Asparagine; D007770:L-Lactate Dehydrogenase; D000410:Alanine Transaminase; D001215:Asparaginase